Keyphrases
Adverse Effects
57%
Anemia
14%
Antiseizure Medication
28%
Cholesterol
14%
Clinical Practice
42%
Close Follow-up
14%
Denmark
14%
Epilepsy
14%
Everolimus
100%
Laboratory Abnormalities
14%
Life-limiting Conditions
14%
Longest Diameter
14%
Nineteen
14%
Norway
14%
Oral Ulceration
14%
Patients with Epilepsy
14%
Placebo-controlled
14%
Real-world Clinical Practice
100%
Renal Angiomyolipoma
57%
Seizure Frequency
14%
Seizure Reduction
28%
Stomatitis
14%
Subependymal Giant Cell Astrocytoma
42%
Treatment Duration
28%
Tuberous Sclerosis Complex
100%
Upper Respiratory Tract Infection
14%
Young Age
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
57%
Anemia
14%
Angiomyolipoma
57%
Everolimus
100%
Mouth Ulcer
14%
Placebo
14%
Stomatitis
14%
Subependymal Giant Cell Astrocytoma
42%
Symptom
14%
Tuberous Sclerosis
100%
Upper Respiratory Tract Infection
14%
Neuroscience
Adverse Effect
57%
Anti-Seizure Medication
28%
Antiseizure Medication
28%
Astrocytoma
42%
Everolimus
100%
Placebo
14%
Tuberous Sclerosis
100%
Upper Respiratory Tract
14%